Molecular and Translational Research of Non-Small Cell Lung Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 69
Special Issue Editor
Interests: lung cancer; precision oncology; immunotherapy; rare cancer; head and neck cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lung cancer continues to be the leading cause of cancer death worldwide, and non-small cell lung cancer (NSCLC) represents the most prevalent form. Recent molecular research has significantly enhanced our understanding of the genetic alterations driving NSCLC development and progression. Key discoveries include the identification of driver mutations in genes such as EGFR, ALK, ROS1, RET, MET, KRAS, BRAF, HER2, and NTRK, which have unraveled the age of precision oncology and have led to the development of targeted therapies with improved patient outcomes and survival. Furthermore, the exploration of the tumor microenvironment and immune evasion mechanisms has paved the way for immune checkpoint inhibitors (ICIs), which have also helped to improve patient outcomes and have facilitated the presence of an increasing percentage of long-term survivors. Both targeted therapy and immunotherapy became part of standard treatment for patients with advanced disease, but now their role is rapidly expanding to earlier stages.
Thanks to this translational research, the prognosis of patients with NSCLC has significantly improved, but there is still much work to be carried out. Moreover, molecular research must continue to discover new driver mutations, resistance mechanisms, and biomarkers.
This Special Issue will encompass the latest advances in NSCLC precision medicine and targeted therapy, new potential driver molecular mechanisms, resistance molecular mechanisms to targeted therapy, molecular biomarkers of efficacy or toxicity to immunotherapy, and resistance molecular mechanisms to immunotherapy, both in advanced and early-stage disease.
Dr. Xabier Mielgo Rubio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-small cell lung cancer
- precision medicine
- targeted therapy
- resistance mechanisms
- immunotherapy
- molecular biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
